<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>4063</number>
    <updateDate>2025-05-27T14:12:59Z</updateDate>
    <updateDateIncludingText>2025-05-27T14:12:59Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2023-06-13</introducedDate>
    <congress>118</congress>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 169, Number 103 (Tuesday, June 13, 2023)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mrs. DINGELL:H.R. 4063.Congress has the power to enact this legislation pursuantto the following:The Constitutional authority of Congress to enact thislegislation is provided by Article I, Section 8 of the UnitedStates Constitution.The single subject of this legislation is:To reauthorize a pilot program for public healthlaboratories to detect fentanyl and other synthetic opioids.[Page H2885]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2023-06-16T18:17:34Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2023-06-13T14:04:05Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Support for Patients and Communities Reauthorization Act</title>
        <congress>118</congress>
        <number>4531</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-12-13</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>SUPPORT for Patients and Communities Reauthorization Act of 2023</title>
        <congress>118</congress>
        <number>2433</number>
        <type>S</type>
        <latestAction>
          <actionDate>2023-07-20</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2023-06-16</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-06-13</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-06-13</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-06-13</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>D000624</bioguideId>
        <fullName>Rep. Dingell, Debbie [D-MI-6]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Dingell</lastName>
        <party>D</party>
        <state>MI</state>
        <district>6</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001257</bioguideId>
        <fullName>Rep. Bilirakis, Gus M. [R-FL-12]</fullName>
        <firstName>Gus</firstName>
        <lastName>Bilirakis</lastName>
        <party>R</party>
        <state>FL</state>
        <middleName>M.</middleName>
        <district>12</district>
        <sponsorshipDate>2023-06-13</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2024-02-12T16:30:25Z</updateDate>
        </item>
        <item>
          <name>Drug trafficking and controlled substances</name>
          <updateDate>2024-02-12T16:30:25Z</updateDate>
        </item>
        <item>
          <name>Health programs administration and funding</name>
          <updateDate>2024-02-12T16:30:25Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-07-18T14:00:31Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-06-13</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2024-06-24T20:21:49Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Federal Interventions and New Detections of Fentanyl Act of 2023 or the FIND Fentanyl Act of 2023&amp;nbsp;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill reauthorizes through FY2028 the pilot program that is administered by the Department of Health and Human Services that supports coordination between public health laboratories and law enforcement in order to better detect fentanyl and other synthetic opioids.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>FIND Fentanyl Act of 2023</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>FIND Fentanyl Act of 2023</title>
        <updateDate>2024-07-24T15:21:32Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>FIND Fentanyl Act of 2023</title>
        <updateDate>2024-05-24T13:38:38Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Federal Interventions and New Detections of Fentanyl Act of 2023</title>
        <updateDate>2024-05-24T13:38:38Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To amend the SUPPORT for Patients and Communities Act to reauthorize a pilot program for public health laboratories to detect fentanyl and other synthetic opioids.</title>
        <updateDate>2024-03-18T20:59:58Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2023-06-13T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr4063ih/xml/BILLS-118hr4063ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-06-16</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
